CFTR and benign prostatic hyperplasia: The NF-κB/COX-2/PGE2 activity negatively regulated by the involvement of the cystic fibrosis transmembrane conductance regulator (CFTR) in human BPH samples provides a mechanistic explanation for the interaction [51].